TNGX Operating Cash Flow (Statement)
Tango Therapeutics Inc · Operating Cash Flow (Statement)
TNGX Operating Cash Flow (Statement)
Latest reported-$143.90Mperiod ending
TNGX TTM Cash from Operations ($70.07M → -$143.90M)
TTM operating cash flow (statement)
High-resolution chart · PNG
TNGX operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -143,896,000 | |
| -141,549,000 | |
| -138,886,000 | |
| -145,815,000 | |
| -148,253,000 | |
| -135,341,000 | |
| -131,501,000 | |
| -122,321,000 | |
| -120,066,000 | |
| -120,932,000 | |
| -117,982,000 | |
| -118,781,000 | |
| -107,257,000 | |
| -114,322,000 | |
| -109,080,000 | |
| -97,716,000 | |
| -99,599,000 | |
| -75,579,000 | |
| -59,527,000 | |
| -60,687,000 | |
| 72,066,000 | |
| 68,589,000 | |
| 70,074,000 |